Setmelanotide Promising in Obesity Caused by Rare Genetic Disorders Setmelanotide Promising in Obesity Caused by Rare Genetic Disorders

Investigational drug impacts hunger and reduces weight in two small, preliminary trials in patients with obesity caused by two rare genetic mutations; agent may have wider uses, says an expert.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Family Medicine/Primary Care News Source Type: news